Company profile for ZYUS Life Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. Our strategy is to focus exclusively on patients by delivering high-quality, consistent and GMP-compliant therapeutic products to the global medical market. Our aim is to shift the paradigm from the treatment of physical disease to caring for overall...
ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. Our strategy is to focus exclusively on patients by delivering high-quality, consistent and GMP-compliant therapeutic products to the global medical market. Our aim is to shift the paradigm from the treatment of physical disease to caring for overall well-being, by accelerating the adoption of phyto-therapeutics. We use science as a driver to establish phyto-therapeutics as a standard of care for treating disease and managing the experience of it.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
204-407 Downey Rd Saskatoon, Saskatchewan S7N 4L8
Telephone
Telephone
1-888-651-9987
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/zyus-life-sciences-activates-first-clinical-site-and-enrolls-first-patient-in-phase-2a-utopia-1-cancer-pain-trial-302538308.html

PR NEWSWIRE
26 Aug 2025

https://www.businesswire.com/news/home/20250715360100/en/ZYUS-Life-Sciences-Strengthens-Clinical-Leadership-with-Appointment-of-Chief-Medical-Officer-to-Support-Phase-2-Oncology-Pain-Trial

BUSINESSWIRE
15 Jul 2025

https://www.businesswire.com/news/home/20250627943504/en/Brent-H.-Zettl-Provides-Update-on-Holdings-of-ZYUS-Life-Sciences-Corporation

BUSINESSWIRE
27 Jun 2025

https://www.businesswire.com/news/home/20250627697326/en/ZYUS-Life-Sciences-Announces-Closing-of-Unit-Offering

BUSINESSWIRE
27 Jun 2025

https://www.businesswire.com/news/home/20250616526235/en/ZYUS-Life-Sciences-Announces-Closing-of-First-Tranche-of-Unit-Offering

BUSINESSWIRE
16 Jun 2025

https://www.businesswire.com/news/home/20250522640382/en/ZYUS-Life-Sciences-Finalizing-Site-Initiation-for-Phase-2A-Clinical-Trial-Advancing-Novel-Non-Opioid-Pain-Drug

BUSINESSWIRE
22 May 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty